Growing community of inventors

Longueuil, Canada

Andre B Charette

Average Co-Inventor Count = 5.40

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 26

Andre B CharetteAlfredo C Castro (4 patents)Andre B CharetteMartin R Tremblay (4 patents)Andre B CharetteMichael J Grogan (4 patents)Andre B CharetteAndre Lescarbeau (4 patents)Andre B CharetteBrian C Austad (4 patents)Andre B CharetteMark L Behnke (4 patents)Andre B CharetteStephane Peluso (4 patents)Andre B CharetteSomarajannair Janardanannair (4 patents)Andre B CharetteAlessandro Boezio (1 patent)Andre B CharetteAlexandre Lemire (1 patent)Andre B CharetteJean-Christophe Poupon (1 patent)Andre B CharetteAlexandre Cote (1 patent)Andre B CharetteAndre B Charette (6 patents)Alfredo C CastroAlfredo C Castro (114 patents)Martin R TremblayMartin R Tremblay (47 patents)Michael J GroganMichael J Grogan (44 patents)Andre LescarbeauAndre Lescarbeau (32 patents)Brian C AustadBrian C Austad (31 patents)Mark L BehnkeMark L Behnke (28 patents)Stephane PelusoStephane Peluso (26 patents)Somarajannair JanardanannairSomarajannair Janardanannair (24 patents)Alessandro BoezioAlessandro Boezio (19 patents)Alexandre LemireAlexandre Lemire (4 patents)Jean-Christophe PouponJean-Christophe Poupon (2 patents)Alexandre CoteAlexandre Cote (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Infinity Pharmaceuticals, Inc. (4 from 108 patents)

2. Other (1 from 832,843 patents)

3. Valorisation-recherche, Limited Partnership (1 from 43 patents)

4. Infinity Discovery, Inc. (12 patents)


6 patents:

1. 11007181 - Cyclopamine analogs

2. 10406139 - Cyclopamine analogs

3. 9951083 - Cyclopamine analogs

4. 9492435 - Cyclopamine analogs

5. 8492574 - Methods for preparing dioranozinc compounds

6. 8067440 - Phosphonium salts derivatives and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/25/2025
Loading…